tryptophan has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bader, B; Batra, AS; Baumann, D; Carretero, R; Cichon, F; Elmadany, N; Gorjánácz, M; Gutcher, I; Hartung, IV; Irlbacher, H; Kober, C; Kreft, B; Leder, G; Lefranc, J; Lesche, R; Oezcan-Wahlbrink, M; Oezen, I; Offringa, R; Olesch, C; Opitz, CA; Platten, M; Prinz, F; Roehn, U; Roese, L; Roewe, J; Roider, HG; Sadik, A; Sahm, K; Schmees, N; Stoeckigt, D; Weinmann, H | 1 |
Boehm, A; Dietz, A; Fischer, M; Herbarth, O; Mozet, C; Opitz, P; Seidel, A; Wichmann, G | 1 |
2 other study(ies) available for tryptophan and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Dioxygenases; Head and Neck Neoplasms; Humans; Immunologic Factors; Immunotherapy; Kynurenine; Leukocytes, Mononuclear; Lung Neoplasms; Mice; Receptors, Aryl Hydrocarbon; Squamous Cell Carcinoma of Head and Neck; Tryptophan; Tumor Microenvironment | 2023 |
Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer?
Topics: Biomarkers, Tumor; Case-Control Studies; Chromatography, High Pressure Liquid; Creatinine; Female; Guanosine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nucleosides; Ribonucleosides; Squamous Cell Carcinoma of Head and Neck; Tryptophan; Xanthines | 2018 |